Alchol Abuse and Metabolic Syndrome Promote Desmoplasia of Pancreatic Cancer
酒精滥用和代谢综合征促进胰腺癌结缔组织增生
基本信息
- 批准号:8401917
- 负责人:
- 金额:$ 20.69万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-08-01 至 2017-07-31
- 项目状态:已结题
- 来源:
- 关键词:1-Phosphatidylinositol 3-KinaseAdenocarcinomaAlcohol abuseAlcoholsAngiogenic FactorAnimal ModelCellsChemicalsChronicClinicalDevelopmentDietDietary FactorsDuctalEthanolExtracellular MatrixExtracellular Matrix ProteinsFatty acid glycerol estersGlandGrowthGrowth FactorImmuneInstructionInsulin-Like Growth Factor ILeadLeptinLipopolysaccharidesMalignant NeoplasmsMalignant neoplasm of pancreasMeasuresMediatingMediator of activation proteinMetabolic syndromeModelingNeoplasm MetastasisOutcomePancreasPancreatic AdenocarcinomaPancreatic Ductal AdenocarcinomaPancreatic Intraepithelial NeoplasiaParticipantPrincipal InvestigatorProductionReactionRoleSHH geneSignal TransductionSolid NeoplasmSourceSystemTestingThe SunTherapeuticTissuesTumor Necrosis Factor-alphaalcohol effectalcohol responsecancer cellcarcinogenesisfeedinghuman FRAP1 proteinin vivoinsightnoveloxidized low density lipoproteinprogramsresponsescaffoldstellate celltumor
项目摘要
Pancreatic ductal adenocarcinoma (PDAC) is unique among solid tumors because of the extremely dense
desmoplasfic reaction that surrounds the cancer cell glands of this tumor. The cancer desmoplasia is
produced by the myofibroblasfic activated pancreatic stellate cell (PaSC) The PaSCs when acfivated
produce large amounts of extracellular matrix (ECM) proteins and modulate the growth of PDAC by providing
a scaffold for the cancer cells to grow as well as growth factors, angiogenesis factors and immune
modulators. Evidence is mounting that interplay between the cancer cells and activated PaSCs are
responsible for the growth, metastasis and chemoresistance of PDAC. We propose that various systemic
factors occurring in alcohol abuse and high fat/high calorie diet (HFCD) stimulate conversion of the
endogenous quiescent PaSCs to their activated, myofibroblasfic and pancreafic cancer promoting state. In
this state the stellate cell is a key participant in pancreafic carcinogenesis. Our hypothesis states that alcohol
abuse and HFCD promote desmoplasia and, in turn, promote the development of pancreafic cancer through
the effects of alcohol metabolites, lepfin, insulin-like growth factor-1 (IGF-1), lipopolysaccharide (LPS), tumor
necrosis factor-a (TNF-a) and oxidized low density lipoprotein (oxLDL) on PaSCs. These mediators act on
PaSCs resulting in their activation, proliferation, production of extracellular matrix proteins and chemical
signals that are essential for promotion of pancreatic cancer. These effects are mediated in large part
through the PI 3kinase/Akt and mTOR signaling systems of PaSCs. Also, these systemic factors interact with
cancer precursors PanIN cells regulafing their PI3kinase/Akt and mTOR signaling systems resulfing in the
secretion of factors that additionally promote the procarcinogenic effects of the PaSCs. To test our
hypothesis the following Specific Aims are proposed: 1) to characterize the effects of ethanol (and its
metabolites), lepfin, IGF-1, LPS, TNF-a, oxLDL on PaSC pro-carcinogenic responses; 2) to determine the
role of the PI 3kinase/ Akt and mTOR signaling system in PaSC procarcinogenic responses; 3) to examine
the effects of ethanol feeding on PaSC responses and PanlNs progression in the conditional Kras¿^^¿ model
subjected to standard or high caloric diets; and 4) to determine PaSC responses in vivo in the animal models
ofthe program.
RELEVANCE (See instructions):
Our invesfigations will demonstrate how alcohol and dietary factors infiuence pancreatic carcinogenesis
through their effects on the pancreatic stellate cell which represents the source of cancer desmoplasia.
Because of emerging information showing the important role of the stellate cell and desmoplasia in
pancreatic carcinogenesis, our results will lead to novel and likely unexpected insights about the mechanism
of promotion of pancreatic cancer leading to important preventative and therapeutic clinical strategies.
胰腺导管腺癌(PDAC)是实体瘤中的独特之处,因为它具有极高的密度,
肿瘤的癌细胞腺体周围的结缔组织增生反应。癌性结缔组织增生是
由成肌纤维细胞活化的胰腺星状细胞(PaSC)产生。
产生大量的细胞外基质(ECM)蛋白,并通过提供
癌细胞生长的支架以及生长因子、血管生成因子和免疫调节因子,
调制器。越来越多的证据表明,癌细胞和激活的PaSC之间的相互作用是
负责PDAC的生长、转移和化学抗性。我们建议,各种系统
酒精滥用和高脂肪/高热量饮食(HFCD)中发生的因素刺激了
在一些实施方案中,细胞因子可将内源性静止PaSC转化为其活化的、肌纤维母细胞和胰腺癌促进状态。在
在这种状态下,星状细胞是胰腺癌发生的关键参与者。我们的假设是酒精
滥用和HFCD促进结缔组织增生,反过来又促进胰腺癌的发展,
酒精代谢产物、瘦素、胰岛素样生长因子-1(IGF-1)、脂多糖(LPS)、肿瘤
坏死因子-α(TNF-α)和氧化低密度脂蛋白(oxLDL)。这些调解人采取行动,
PaSC导致其活化、增殖、产生细胞外基质蛋白和化学物质
这些信号对促进胰腺癌的发生至关重要。这些影响在很大程度上是由
通过PaSCs的PI 3激酶/Akt和mTOR信号系统。此外,这些系统性因素与
癌前体PanIN细胞调节其PI 3激酶/Akt和mTOR信号系统,导致
分泌额外促进PaSC的原致癌作用的因子。来测试我们
假设提出了以下具体目的:1)表征乙醇(及其
代谢物)、瘦素、IGF-1、LPS、TNF-α、oxLDL对PaSC促癌反应的影响; 2)确定
PI 3激酶/ Akt和mTOR信号系统在PaSC致癌反应中的作用; 3)检查
在条件Kras模型中,乙醇喂养对PaSC反应和PanLN进展的影响
进行标准或高热量饮食;和4)在动物模型中测定体内PaSC应答
的程序。
相关性(参见说明):
我们的研究将证明酒精和饮食因素如何影响胰腺癌的发生
通过它们对胰腺星状细胞的作用,而星状细胞是癌症结缔组织增生的来源。
由于新出现的信息显示星状细胞和结缔组织增生在
胰腺癌的发生,我们的研究结果将导致新的和可能意想不到的见解的机制
促进胰腺癌导致重要的预防和治疗临床策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
STEPHEN J PANDOL其他文献
STEPHEN J PANDOL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('STEPHEN J PANDOL', 18)}}的其他基金
Project 3: Role of the pancreatic fibroinflammatory microenvironment in obesity-promoted pancreatic cancer
项目3:胰腺纤维炎症微环境在肥胖促进的胰腺癌中的作用
- 批准号:
10398847 - 财政年份:2020
- 资助金额:
$ 20.69万 - 项目类别:
Project 3: Role of the pancreatic fibroinflammatory microenvironment in obesity-promoted pancreatic cancer
项目3:胰腺纤维炎症微环境在肥胖促进的胰腺癌中的作用
- 批准号:
10605240 - 财政年份:2020
- 资助金额:
$ 20.69万 - 项目类别:
Project 3 - HDAC/GSK-3B/YAP signaling network in the liver metastatic microenvironment
项目3-肝转移微环境中的HDAC/GSK-3B/YAP信号网络
- 批准号:
10331759 - 财政年份:2020
- 资助金额:
$ 20.69万 - 项目类别:
Project 3 - HDAC/GSK-3B/YAP signaling network in the liver metastatic microenvironment
项目3-肝转移微环境中的HDAC/GSK-3B/YAP信号网络
- 批准号:
10558486 - 财政年份:2020
- 资助金额:
$ 20.69万 - 项目类别:
Targeting protein kinase D in alcoholic pancreatitis
靶向蛋白激酶 D 在酒精性胰腺炎中的作用
- 批准号:
9333159 - 财政年份:2016
- 资助金额:
$ 20.69万 - 项目类别:
Alchol Abuse and Metabolic Syndrome Promote Desmoplasia of Pancreatic Cancer
酒精滥用和代谢综合征促进胰腺癌结缔组织增生
- 批准号:
8561433 - 财政年份:2013
- 资助金额:
$ 20.69万 - 项目类别:
Alcohol and the Exocrine Pancreas ER Stress Responses
酒精与外分泌胰腺 ER 应激反应
- 批准号:
7025120 - 财政年份:2006
- 资助金额:
$ 20.69万 - 项目类别:
相似国自然基金
大肠癌发生机制的adenoma-adenocarcinoma pathway同serrated pathway的关系的研究
- 批准号:30840003
- 批准年份:2008
- 资助金额:12.0 万元
- 项目类别:专项基金项目
相似海外基金
Synergistic Radiosensitization of Hypoxic Pancreatic Adenocarcinoma using Gd-Texaphyrin Oxygen-Loaded Nanodroplets
使用 Gd-Texaphyrin 载氧纳米液滴对缺氧胰腺腺癌进行协同放射增敏
- 批准号:
478914 - 财政年份:2023
- 资助金额:
$ 20.69万 - 项目类别:
Operating Grants
Expression mechanism of immune checkpoint molecules after carbon-ion radiotherapy in cervical adenocarcinoma specimens
宫颈腺癌碳离子放疗后免疫检查点分子的表达机制
- 批准号:
23K14913 - 财政年份:2023
- 资助金额:
$ 20.69万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Study of fibrosis in pancreatic ductal adenocarcinoma (PDAC) and application of adipose-derived stromal/stem cells for PDAC treatment
胰腺导管腺癌(PDAC)纤维化的研究以及脂肪源性基质/干细胞在 PDAC 治疗中的应用
- 批准号:
23K15035 - 财政年份:2023
- 资助金额:
$ 20.69万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Therapeutic Targeting of NSD2 in Lung Adenocarcinoma
NSD2 在肺腺癌中的治疗靶向
- 批准号:
10657069 - 财政年份:2023
- 资助金额:
$ 20.69万 - 项目类别:
IRAK4 AS A NOVEL IMMUNOTHERAPEUTIC TARGET IN PANCREATIC DUCTAL ADENOCARCINOMA
IRAK4 作为胰腺导管腺癌的新型免疫治疗靶点
- 批准号:
10442874 - 财政年份:2023
- 资助金额:
$ 20.69万 - 项目类别:
Molecular mechanisms for development of pulmonary invasive mucinous adenocarcinoma
肺浸润性粘液腺癌发生的分子机制
- 批准号:
23H02698 - 财政年份:2023
- 资助金额:
$ 20.69万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Control mechanisms of lung adenocarcinoma by SGLT2 inhibitors for treating diabetes mellitus.
SGLT2抑制剂治疗糖尿病对肺腺癌的控制机制。
- 批准号:
23K08326 - 财政年份:2023
- 资助金额:
$ 20.69万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Establishment of histological transformation model from lung small cell carcinoma from adenocarcinoma to explore the therapeutic strategies of small cell lung carcinoma.
建立肺小细胞癌腺癌组织学转化模型,探讨小细胞肺癌的治疗策略。
- 批准号:
23K14614 - 财政年份:2023
- 资助金额:
$ 20.69万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms of tumor progression controlled by tumor-initiating cells and cancer-associated fibroblasts in pancreatic adenocarcinoma.
阐明胰腺腺癌中肿瘤起始细胞和癌症相关成纤维细胞控制的肿瘤进展机制。
- 批准号:
23K15075 - 财政年份:2023
- 资助金额:
$ 20.69万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidating the Cellular Origins of lung adenocarcinoma
阐明肺腺癌的细胞起源
- 批准号:
10743611 - 财政年份:2023
- 资助金额:
$ 20.69万 - 项目类别:














{{item.name}}会员




